Walgreens Boots Alliance, Inc. (WBA) To Go Ex-Dividend on May 20th

Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) announced a quarterly dividend on Thursday, April 25th, Zacks reports. Shareholders of record on Tuesday, May 21st will be given a dividend of 0.25 per share by the pharmacy operator on Wednesday, June 12th. This represents a $1.00 dividend on an annualized basis and a yield of 5.50%. The ex-dividend date is Monday, May 20th.

Walgreens Boots Alliance has increased its dividend payment by an average of 1.3% annually over the last three years. Walgreens Boots Alliance has a dividend payout ratio of 31.6% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Walgreens Boots Alliance to earn $3.13 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 31.9%.

Walgreens Boots Alliance Stock Down 0.9 %

Shares of WBA opened at $18.18 on Friday. The stock’s 50-day moving average price is $18.91 and its two-hundred day moving average price is $21.32. Walgreens Boots Alliance has a 12 month low of $17.12 and a 12 month high of $32.89. The company has a market capitalization of $15.68 billion, a PE ratio of -2.60, a PEG ratio of 1.14 and a beta of 0.80. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period in the prior year, the firm posted $1.16 EPS. The company’s quarterly revenue was up 6.3% on a year-over-year basis. On average, analysts anticipate that Walgreens Boots Alliance will post 3.23 EPS for the current year.

Wall Street Analyst Weigh In

WBA has been the subject of several recent analyst reports. UBS Group reduced their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. Truist Financial reiterated a “hold” rating and issued a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. SVB Leerink reduced their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research note on Monday, March 18th. Finally, TD Cowen cut their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $24.36.

Read Our Latest Research Report on WBA

Insider Activity

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Dividend History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.